Stocks

If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Name	Symbol	Analysis date	Close	+/- %
Acer Incorporated	AC5G	Apr 25, 2025	4.00	+25.00
ACERINOX ADR 1/2/EO-,25	ACE	Apr 25, 2025	4.82	+3.43
Acerinox SA	ACE1	Apr 25, 2025	10.09	+4.72
Achieve Life Sciences, Inc. -	SP4P	Apr 25, 2025	2.08	+13.54
Achilles Therapeutics plc - American Depositary Shares	698	Apr 25, 2025	1.33	0.00
ACI Worldwide, Inc.	TSA	Apr 25, 2025	45.80	+1.33
ACINQUE S.P.A. EO 1	YA2	Apr 25, 2025	2.02	+1.00
Ackermans & van Haaren NV	B3K	Apr 25, 2025	210.20	+4.06
Aclara Resources Inc	JD1	Apr 25, 2025	0.43	+7.04
Aclaris Therapeutics, Inc.	8AT	Apr 25, 2025	1.11	+11.78
ACM Research, Inc. - Class A	813	Apr 25, 2025	18.38	+6.74
Acma Ltd	AAX1	Apr 25, 2025	0.01	+68.75
Acme United Corporation.	UT1	Apr 25, 2025	37.00	+5.71
Acom Co Ltd	AK5	Apr 25, 2025	2.38	+6.25
aconnic AG	CFC	Apr 25, 2025	0.95	+4.37
Acotec Scientific Holdings Limited	7W3	Apr 25, 2025	0.84	+11.18
AcouSort	4SA	Apr 25, 2025	0.27	+1.13
ACRES Commercial Realty D Pref	R9L0	Apr 25, 2025	17.60	-5.38
Acrinova A	9M0	Apr 25, 2025	0.97	+10.86
ACROUD	7NG	Apr 25, 2025	0.00	+200.00
Acrow Formwork and Construction Services Limited	59Y	Apr 25, 2025	0.59	+1.72
Acrux Ltd	FJY	Apr 25, 2025	0.01	+25.00
ACS A.DE C.ADR 1/5/EO-,50	OCI	Apr 25, 2025	10.60	+1.92
ACS Actividades de Construccion y Servicios SA	OCI1	Apr 25, 2025	53.45	+4.50
Actia Group	AG9	Apr 25, 2025	2.90	+6.23
Actic Group	8XA	Apr 25, 2025	1.52	+41.20
Actinium Pharmaceuticals, Inc. (Delaware)	7AY1	Apr 25, 2025	1.10	+1.20
Actinogen Medical Limited	3AC	Apr 25, 2025	0.01	0.00
Active Biotech	BTPC	Apr 25, 2025	0.01	-3.51
ActiveOps Plc	95D	Apr 25, 2025	1.16	+21.47

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.